ArticlePloS one2025
Unveiling CNS cell morphology with deep learning: A gateway to anti-inflammatory compound screening.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deciphering the complex relationships between cellular morphology and phenotypic manifestations is crucial for understanding cell behavior, particularly in the context of neuropathological states. Despite its importance, the application of advanced image analysis methodologies to central nervous system (CNS) cells, including neuronal and glial cells, has been limited. Furthermore, cutting-edge techniques in the field of cell image analysis, such as deep learning (DL), still face challenges, including the requirement for large amounts of labeled data, difficulty in detecting subtle cellular changes, and the presence of batch effects. Our study addresses these shortcomings in the context of neuroinflammation. Using our in-house data and a DL-based approach, we have effectively analyzed the morphological phenotypes of neuronal and microglial cells, both in pathological conditions and following pharmaceutical interventions. This innovative method enhances our understanding of neuroinflammation and streamlines the process for screening potential therapeutic compounds, bridging a gap in neuropathological research and pharmaceutical development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.